Bolouri H, Farrar JE, Triche T, Ries RE, Lim EL, Alonzo TA, et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat Med. 2018;24:103–12.

Article  CAS  PubMed  Google Scholar 

Conneely SE, Rau RE. The genomics of acute myeloid leukemia in children. Cancer Metastasis Rev. 2020;39:189–209.

Article  PubMed  PubMed Central  Google Scholar 

Lew-Derivry L, Marceau-Renaut A, Fenwarth L, Cuccuini W, Ballerini P, Ferreboeuf M, et al. Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group. Leukemia. 2023;37:1723–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conneely SE, Stevens AM. Acute myeloid leukemia in children: emerging paradigms in genetics and new approaches to therapy. Curr Oncol Rep. 2021;23:16.

Article  PubMed  PubMed Central  Google Scholar 

Qiu K, Liao X, Li Y, Huang K, Xu H, Fang J, et al. Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16). BMC Cancer. 2023;23:476.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lasry A, Nadorp B, Fornerod M, Nicolet D, Wu H, Walker CJ et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat Cancer. 2023;4:27–42.

Bailur JK, McCachren SS, Pendleton K, Vasquez JC, Lim HS, Duffy A, et al. Risk-associated alterations in marrow T cells in pediatric leukemia. JCI Insight. 2020;5:e140179.

Article  PubMed  PubMed Central  Google Scholar 

Lambo S, Trinh DL, Ries RE, Jin D, Setiadi A, Ng M, et al. A longitudinal single-cell atlas of treatment response in pediatric AML. Cancer Cell. 2023;41:2117–2135.e12.

Article  CAS  PubMed  Google Scholar 

Mumme H, Thomas BE, Bhasin SS, Krishnan U, Dwivedi B, Perumalla P, et al. Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia. Nat Commun. 2023;14:6209.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Rhenen A, Feller N, Kelder A, Westra AH, Rombouts E, Zweegman S, et al. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clin Cancer Res. 2005;11:6520–7.

Article  PubMed  Google Scholar 

Elsayed AH, Rafiee R, Cao X, Raimondi S, Downing JR, Ribeiro R, et al. A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia. Leukemia. 2020;34:735–45.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Jiang S, He F, Tian Y, Hu H, Gao L, et al. Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML. Genome Biol. 2023;24:199.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hay SB, Ferchen K, Chetal K, Grimes HL, Salomonis N. The Human Cell Atlas bone marrow single-cell interactive web portal. Exp Hematol. 2018;68:51–61.

Article  PubMed  PubMed Central  Google Scholar 

Pullarkat ST, Pullarkat V, Lagoo A, Brynes R, Weiss LM, Bedell V, et al. Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1. Leuk Res. 2013;37:1572–5.

Article  CAS  PubMed  Google Scholar 

Cook JA, Lott L, Perry J, Nalla A, Xu D, Hudson CA, et al. Residual mast cells can explain persistent molecular positivity in difference from normal flow cytometric-defined MRD negative core binding factor AML. Blood. 2023;142:426–426.

Article  Google Scholar 

Mahadeo KM, Wolgast L, McMahon C, Cole PD. Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia. Pediatr Blood Cancer. 2011;57:684–7.

Article  PubMed  Google Scholar 

Sharma S, Harbhajanka A, Jain A, Seth A. Systemic mastocytosis with an associated non mast cell lineage clonal hematological disease in a child. Indian J Pathol Microbiol. 2011;54:854–6.

Article  PubMed  Google Scholar 

Rabade N, Tembhare P, Patkar N, Amare P, Arora B, Subramanian P, et al. Childhood systemic mastocytosis associated with t (8; 21) (q22; q22) acute myeloid leukemia. Indian J Pathol Microbiol. 2016;59:407.

Article  PubMed  Google Scholar 

Yabe M, Masukawa A, Kato S, Yabe H, Nakamura N, Matsushita H. Systemic mastocytosis associated with t(8;21) acute myeloid leukemia in a child: Detection of the D816A mutation of KIT. Pediatr Blood Cancer. 2012;59:1313–6.

Article  PubMed  Google Scholar 

Intzes S, Wiersma S, Meyerson HJ. Myelomastocytic leukemia with t(8;21) in a 3-year-old child. J Pediatr Hematol Oncol. 2011;33:e372–5.

Article  PubMed  Google Scholar 

Gogia A, Sharawat SK, Kumar R, Sarkar C, Bakhshi S. Systemic mastocytosis associated with childhood acute myeloid leukemia. J Pediatr Hematol Oncol. 2013;35:163–4.

Article  PubMed  Google Scholar 

Sheikh IN, AlQahtani S, Yin CC, McCall D, Cuglievan B, Ragoonanan D, et al. KIT ‐mutated pediatric core‐binding factor systemic mastocytosis‐acute myeloid leukemia treated with avapritinib and decitabine. Pediatr Blood Cancer. 2024;71:e30898.

Article  CAS  PubMed  Google Scholar 

McGinnis CS, Murrow LM, Gartner ZJ. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 2019;8:329–337.e4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573–3587.e29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ticle T, Tirosh I, Georgescu C, Brown M, Haas B. inferCNV of the Trinity CTAT Project. 2019. https://github.com/broadinstitute/inferCNV.

Yuen K, Liu Y, Zhou Y, Wang Y, Zhou D, Fang J, et al. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/ KMT2A rearrangements. Cancer Med. 2023;12:1418–30.

Article  CAS  PubMed  Google Scholar 

Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang F, Wang X-Y, Wang M-Y, Mao Y, Miao X-L, Wu C-Y, et al. An immune checkpoint-related gene signature for predicting survival of pediatric acute myeloid leukemia. J Oncol. 2021;2021:1–14.

Article  CAS  Google Scholar 

Gao Y, Zhou J-F, Mao J-Y, Jiang L, Li X-P. Identification of the thyrotropin-releasing hormone (TRH) as a novel biomarker in the prognosis for acute myeloid leukemia. Biomolecules. 2022;12:1359.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng Z, Dai Y, Pang Y, Jiao Y, Liu Y, Cui L, et al. High EGFL7 expression may predict poor prognosis in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Cancer Biol Ther. 2019;20:1314–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Langer C, Radmacher MD, Ruppert AS, Whitman SP, Paschka P, Mrózek K, et al. High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. Blood. 2008;111:5371–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Majoros A, Platanitis E, Kernbauer-Hölzl E, Rosebrock F, Müller M, Decker T. Canonical and non-canonical aspects of JAK–STAT signaling: lessons from interferons for cytokine responses. Front Immunol. 2017;8:29.

Piesche M, Hildebrandt Y, Chapuy B, Wulf GG, Trümper L, Schroers R. Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3. Vaccine. 2009;27:4718–23.

Article